ANTITHROMBOTIC THERAPY IN PREVENTION OF CARDIOVASCULAR EVENTS (DEATH, ACUTE MYOCARDIAL INFARCTION, STROKE) IN PATIENTS WITH CHRONIC HEART FAILURE

ANTITHROMBOTIC THERAPY IN PREVENTION OF CARDIOVASCULAR EVENTS (DEATH, ACUTE MYOCARDIAL INFARCTION, STROKE) IN PATIENTS WITH CHRONIC HEART FAILURE

Chronic heart failure is one of the main clinical challenges of modern medicine. The present paper discusses the features of antithrombotic therapy in prevention of cardiovascular events (death, acute myocardial infarction, stroke) in patients with chronic heart failure. It has been specified, which...

Full description

Saved in:

Bibliographic Details
Main Authors:	N.D. Gerasimenko, M.S. Rasin
Format:	Article
Language:	English
Published:	Poltava State Medical University 2017-12-01
Series:	Проблеми екології та медицини
Subjects:	antithrombotic therapy, prevention of vascular events, chronic heart failure
Online Access:	https://ecomed-journal.org/index.php/journal/article/view/98
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
by: A. Y. Rychkov, et al.
Published: (2016-01-01)

Coagulation Disorders in Infective Endocarditis: Role of Pathogens, Biomarkers, Antithrombotic Therapy (Systematic Review)
by: A. S. Pisaryuk, et al.
Published: (2022-07-01)

IATROGENIC EVENTS OF ORAL ANTITHROMBOTIC THERAPY. BETWEEN SCYLLA AND CHARYBDIS
by: L. I. Dvoretsky, et al.
Published: (2016-12-01)

Antithrombotic therapy in clinical practice
by: J.A. Ker, et al.
Published: (2003-03-01)

Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
by: V. I. Petrov, et al.
Published: (2019-03-01)

New Possibilities of Antithrombotic Therapy of Patients with Peripheral and Widespread Atherosclerotic Lesion
by: A. L. Komarov, et al.
Published: (2018-05-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

ANTITHROMBOTIC PROPHYLAXIS RECURRENT PREECLAMPSIA IN PATIENTS WITH THROMBOPHILIA
by: E. V. Zhuravleva, et al.
Published: (2016-06-01)

Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020
by: A. S. Gerasimenko, et al.
Published: (2022-01-01)

Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis)
by: O. V. Reshetko, et al.
Published: (2020-11-01)

Antithrombotic therapy in patients with atrial fibrillation hospitalised with myocardial infarction in 2016-2023: timeliness of clinical guideline adherence
by: K. G. Pereverzeva, et al.
Published: (2025-08-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION
by: N. V. Mikheeva, et al.
Published: (2015-09-01)

ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
by: V. I. Petrov, et al.
Published: (2015-09-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES
by: Ya. P. Dovgalevskiy, et al.
Published: (2016-01-01)

Antithrombotic Therapy and the Nearest Forecast of Pulmonary Embolism in Rutine Clinical Practice (Data of the Regional Vascular Center of the Ryazan Region)
by: N. N. Nikulina, et al.
Published: (2022-05-01)

APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
by: E. A. Ushkalova, et al.
Published: (2017-05-01)

Antithrombotic therapy in the elderly and senile age: the consensus opinion of experts of the Russian Association of Gerontologists and Geriatricians and the National Society of Preventive Cardiology
by: O. N. Tkacheva, et al.
Published: (2021-05-01)

THE EVALUATION OF ANTITHROMBOTIC TREATMENT PRESCRIPTION DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION BY THE DATA OF PROFILE REGISTRY
by: S. Yu. Martsevich, et al.
Published: (2015-02-01)

Cancer history and mortality risk in acute myocardial infarction: Insights from the Japan AMI registry
by: Ayumi Adachi, et al.
Published: (2025-08-01)

Antithrombotic agents and effect on outcomes in ischemic stroke with atrial fibrillation and large artery atherosclerosis: a real-world study
by: Jilu Chen, et al.
Published: (2025-06-01)

WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE
by: E. N. Dankovtseva, et al.
Published: (2015-12-01)

RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
by: I. V. Grajfer, et al.
Published: (2015-12-01)

Antithrombotic strategies after transcatheter aortic valve replacement a network meta-analysis
by: Mengxiao Shi, et al.
Published: (2025-05-01)

Perioperative Management of Patients Receiving Antithrombotic Therapy in Schemes and Algorithms
by: O. N. Dzhioeva, et al.
Published: (2023-01-01)

The Effects of Dual Antiplatelet Therapy on the Occurrence of Recurrent Cardiovascular Events After Myocardial Infarction in Obese Patients
by: Borovyk K., et al.
Published: (2019-04-01)

Extended dual antithrombotic therapy in patients with chronic coronary syndrome — which agent should be added to aspirin?
by: Jacek Kubica, et al.
Published: (2025-06-01)

The correlation between lipoprotein(a) and major adverse cardiovascular events in patients with acute myocardial infarction combined with heart failure with preserved ejection fraction
by: Xiaodong Zhang, et al.
Published: (2025-06-01)

Oral Antithrombotic Medication Is Associated with Improved Visual Outcomes in Eyes with Submacular Hemorrhage from Wet Age-Related Macular Degeneration
by: Hemal P. Patel, MD, et al.
Published: (2025-09-01)

The efficacy and safety of antithrombotic therapy in patients undergoing TAVI: a network meta-analysis
by: Jingxian Han, et al.
Published: (2025-07-01)

Comparative analysis of intramyocardial autotransplantation of postnatal stem cells from peripheral blood and adipose tissue in patients with acute phase of myocardial infarction, ST segment elevation, after effective thrombolytic reperfusion and coronary artery stenting
by: A. N. Kharlamov, et al.
Published: (1970-01-01)

Triglyceride-glucose index: a novel predictor of major adverse cardiovascular events and cerebrovascular events in patients with acute ST-segment elevation myocardial infarction
by: Ruibin Wei, et al.
Published: (2025-05-01)

Enhanced management strategy of synchronous percutaneous biopsy and microwave ablation in patients with lung ground-glass opacities undergoing antithrombotic treatment: a clinical perspective on our experience
by: Nan Wang, et al.
Published: (2025-07-01)

Risk assessment and prevention of cardiovascular events in patients with obstructive sleep apnea syndrome: A narrative review
by: Bin Li, et al.
Published: (2025-09-01)

Coronary Artery Disease with a High Risk of Complications: How to Identify Such Patients and Choose Management Tactics?
by: S. G. Kanorskii
Published: (2020-07-01)

Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City
by: A. A. Tuchkov, et al.
Published: (2019-03-01)

Antithrombotic Therapy after Bleeding in Elderly Polimorbid Patient: Our Time Challenge
by: M. R. Atabegashvili, et al.
Published: (2018-09-01)

Gastro-Intestinal Tract Complications During Antithrombotic Therapy
by: E. V. Moroz, et al.
Published: (2018-07-01)

Antithrombotic Therapy in Patients with Malignant Lymphoproliferative Disorders Treated with Ibrutinib
by: EI Emelina, et al.
Published: (2019-09-01)

Adherence to therapy and the risk of cardiovascular events in patients with heart failure: data from the outpatient registry
by: E. T. Guseinova, et al.
Published: (2022-11-01)

Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 2: Treatment Options
by: V. G. Grachev, et al.
Published: (2021-05-01)